Other News To Note
• Microbix Biosystems Inc., of Toronto, and Zydus Cadila, of Ahmedabad, India, signed a letter of intent to market thrombolytic drug Urokinase in North American markets. Microbix acquired rights to the drug in 2008. Financial terms were not disclosed.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter